This study, built upon previous reports that have identified necroptosis in COPD (8, 13), shows the essential role of necroptosis in development of emphysema and that inhibition of CS-induced necroptosis by RIP3 inhibitor GSK’872 protects mice from smoking-induced inflammation and subsequent emphysema. The gene discussed is RIPK3; the disease is pulmonary emphysema.